Back to search
Von Willebrand Disease, Type 1
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Von Willebrand Disease, Type 1 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Von Willebrand Disease, Type 1 trials you may qualify forA web-based registry will be created by the sponsor, VWD Connect Foundation (VCF), to collect data on patients with severe Von Willebrand Disease (sVWD). Data w…
The purpose of this screening study is to accumulate information regarding bleeding events, quality of life, and the social and clinical impact of bleeds in par…
This is a first-in-human (FIH), Phase 1/2, open-label, dose escalation, safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and efficacy study of…
Primary Objective: -To characterize the pharmacokinetics (PK) of BIVV001 after a single intravenous (IV) administration, as assessed by factor VIII (FVIII) act…
The objectives of this study are to determine if transcutaneous auricular neurostimulation (tAN) can modulate hemostasis, improve perceived quality of life, and…